Chrisy Ngilneii's Profile

B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)

Chrisy Ngilneii

Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on view more..

Written / Edited / Medically Reviewed

Detecting Lynch Syndrome Among Colorectal Cancer (CRC) Patients

Detecting Lynch Syndrome Among Colorectal Cancer (CRC) Patients

Up-front tumor sequencing in colorectal cancer is simpler and has superior sensitivity to current multitest approaches to Lynch syndrome screening, while simultaneously providing critical information for treatment selection.

Health Watch
Discovery of How Cells Grow in Ovarian Cancer may Lead to New Therapy

Discovery of How Cells Grow in Ovarian Cancer may Lead to New Therapy

Cellular pathway that selectively regulates a mutant protein, called p53-R175H, linked to ovarian cancer growth has been identified by a research team. This discovery opens the possibility of developing a novel way to fight ovarian cancer.

Health Watch
Depression a Risk of Dementia and Mild Cognitive Impairment

Depression a Risk of Dementia and Mild Cognitive Impairment

Individuals with worse depression and mood symptoms are more likely to develop Mild Cognitive Impairment (MCI) and to progress from MCI to dementia. Evaluation and treatment of symptoms of depression may improve or maintain cognitive functioning in some older patients diagnosed with MCI.

Health Watch
Method to Block Chemotherapy-induced Neuropathic Pain Identified

Method to Block Chemotherapy-induced Neuropathic Pain Identified

Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms, recent research finds. The development of chemotherapy-induced neuropathic pain (CINP) compromises the use of chemotherapy and greatly impacts thousands of lives.

Health Watch
New Silver-based Chemotherapy Drug Kills Cancer Cells

New Silver-based Chemotherapy Drug Kills Cancer Cells

Silver-based anti-cancer drug has been discovered by researchers in South Africa. The effective induction of cell death by a silver(I) thiocyanate 4-methoxyphenyl phosphine complex in a malignant esophageal cell line seen in this study has been reported by recent research.

Health Watch